Why is Teleflex executing a $250 million ASR now?

Teleflex completed the sale of its OEM business to Montagu and Kohlberg for $1.5 billion in cash ($1.25 billion after-tax), which has been deployed to reduce debt and fund capital returns. The company states that the ASR and future repurchases will be primarily funded by proceeds from this and other anticipated strategic divestitures, reflecting its disciplined capital allocation strategy.

What was the average price paid per share in the Q2 open-market buyback?

During the second quarter of 2026, Teleflex repurchased 1.9 million shares at an average price of $130.85 per share for a total of $250 million through Rule 10b-18 open-market purchases.

How does this buyback affect Teleflex's share count and EPS?

The $250 million Q2 buyback reduced outstanding shares by approximately 1.9 million, or about 4.3% of Q2 diluted weighted-average shares outstanding (43.7 million). The company's updated 2026 adjusted diluted EPS guidance ($6.90–$7.20) reflects the benefit of this buyback execution and assumes further repurchase activity under the $1 billion program.

What execution mechanism will be used for the ASR?

The filing announces an accelerated share repurchase (ASR) program effective August 7, 2026, but does not disclose the specific financial terms, settlement timeline, or pricing mechanism. The prior Q2 buybacks were executed through Rule 10b-18 open-market purchases.

Is this buyback in addition to debt reduction?

Yes. Teleflex is simultaneously reducing debt and repurchasing shares from OEM divestiture proceeds. In the six months ended June 30, 2026, the company paid off approximately $700 million of Term Loan A-2 debt and repurchased $250 million of common stock, demonstrating a multi-pronged capital allocation approach.

TFX 8-K Filed 2026-08-06 Execution disclosure

Teleflex authorizes $250M accelerated share repurchase, executes $250M Q2 buyback

Medical-device maker deploys OEM divestiture proceeds to reduce debt and return capital via ASR program; $750M remains under $1B authorization

Shares repurchased1.9M

Avg price paid$130.85

Remaining$750M

MechanismAccelerated Share Repurchase (

What the filing says

Teleflex Incorporated announced the execution of a $250 million accelerated share repurchase (ASR) program, effective August 7, 2026, under its previously authorized $1 billion share-repurchase authorization granted by the Board on December 9, 2025. The announcement follows the company's repurchase of 1.9 million shares in the second quarter of 2026 through open-market purchases at an average price of $130.85 per share, also for $250 million.

The ASR and prior Q2 open-market repurchases are part of Teleflex's disciplined capital-allocation strategy following the completion of its OEM business divestiture to Montagu and Kohlberg for $1.5 billion in cash (approximately $1.25 billion after-tax proceeds). The company is deploying divestiture proceeds to reduce debt—including a $700 million paydown of Term Loan A-2—and to return capital to shareholders through buybacks.

As of June 30, 2026, Teleflex had $750 million remaining available under the $1 billion authorization. The company stated that the ASR and future repurchases under the program will be "primarily funded with proceeds from the Strategic Divestitures," which include the completed OEM sale and anticipated closings of Acute Care and Interventional Urology divestiture agreements. The company does not disclose an expiration date for the $1 billion authorization in this filing.

Teleflex's $250 million Q2 buyback and announced ASR represent a capital return initiative funded by proceeds from the strategic sale of its OEM business. The execution of $250 million in Q2 buybacks at a weighted average price of $130.85 per share reduced outstanding share count by approximately 1.9 million shares, or roughly 4.3% of the company's Q2 weighted-average diluted share count of 43.7 million. The $750 million remaining under the $1 billion authorization provides the company with continued flexibility to repurchase shares over time. Notably, the buyback program is concurrent with debt reduction, signaling a multi-pronged approach to balance-sheet strengthening and shareholder returns in a post-acquisition integration period, though the filing does not disclose the ASR settlement terms or timeline.

Also under the $1 billion share repurchase program, the Company intends to commence an accelerated share repurchase of $250 million of common stock, effective August 7, 2026. — TELEFLEX INC 8-K filing · View on SEC EDGAR →

What this means

Frequently asked questions

Why is Teleflex executing a $250 million ASR now?: Teleflex completed the sale of its OEM business to Montagu and Kohlberg for $1.5 billion in cash ($1.25 billion after-tax), which has been deployed to reduce debt and fund capital returns. The company states that the ASR and future repurchases will be primarily funded by proceeds from this and other anticipated strategic divestitures, reflecting its disciplined capital allocation strategy.
What was the average price paid per share in the Q2 open-market buyback?: During the second quarter of 2026, Teleflex repurchased 1.9 million shares at an average price of $130.85 per share for a total of $250 million through Rule 10b-18 open-market purchases.
How much buyback authorization remains?: As of June 30, 2026, Teleflex had $750 million remaining under its $1 billion share-repurchase authorization granted by the Board on December 9, 2025. The company has not disclosed an expiration date for this authorization in this filing.
How does this buyback affect Teleflex's share count and EPS?: The $250 million Q2 buyback reduced outstanding shares by approximately 1.9 million, or about 4.3% of Q2 diluted weighted-average shares outstanding (43.7 million). The company's updated 2026 adjusted diluted EPS guidance ($6.90–$7.20) reflects the benefit of this buyback execution and assumes further repurchase activity under the $1 billion program.
What execution mechanism will be used for the ASR?: The filing announces an accelerated share repurchase (ASR) program effective August 7, 2026, but does not disclose the specific financial terms, settlement timeline, or pricing mechanism. The prior Q2 buybacks were executed through Rule 10b-18 open-market purchases.
Is this buyback in addition to debt reduction?: Yes. Teleflex is simultaneously reducing debt and repurchasing shares from OEM divestiture proceeds. In the six months ended June 30, 2026, the company paid off approximately $700 million of Term Loan A-2 debt and repurchased $250 million of common stock, demonstrating a multi-pronged capital allocation approach.

execution asr mega-cap rule-10b-18 debt-reduction strategic-divestiture

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.